GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

As many as 70% of those living with HIV are expected to be 50 or older by 2030. They often need skilled nursing earlier than ...

A new way of getting high is “tearing the roof off” Fiji’s HIV infection rate, said The Fiji Times. “Bluetoothing” sees intravenous drug users “plunging a syringe” of methamphetamine into a vein, then ...

A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment? Dr. Madeleine ...

Background: Until December 2024, China had identified and named 66 new HIV-1 recombinant genotypes. Among them, CRF85-BC is showing a rapidly growing trend in popularity in southwestern China, ...

Florida will get $3 million as part of a nationwide settlement between the federal government, most state governments and Gilead Sciences, a drug manufacturer accused of giving kickbacks to doctors to ...